Adding Value with Patent Protection for Novel, Tailor-Made Bacterial Production Strains

August 16, 2022 

    • Tags:

Vectron Biosolutions CEO Trond Erik Vee Aune, Ph.D., discusses the exclusive licenses that Vectron currently grants to customers for the specific E. coli strains developed for their programs and how the company will soon offer customers the option of patenting the strains for further protection.

    • Tags:

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Q: